FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312087893> ?p ?o ?g. }

• W4312087893 abstract "Background We developed the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) to address the shortage of qualified investigators with adequate training and expertise to conduct Alzheimer’s Disease (AD) and AD Related Dementias (ADRD) clinical trials. Method We describe the experience of the first two years of funding of the IMPACT-AD course, specifically the rates of applications to the course, descriptive summaries of the accepted trainees, and the measures of participant satisfaction and learning. Result Over the first two years of the course, we received 195 eligible applications to the course. Most (n = 121, 62%) applicants were female and nearly half self-reported as being African American/Black, Asian, or Pacific Islander race and/or Hispanic/Latino ethnicity. Forty-one applicants (21%) indicated that they were the first in their family to attend college Of 69 total trainees accepted to the course (36% acceptance rate), a majority (n = 44, 64%) were female. Twenty-eight (41%) self-reported as being African American/Black, Asian, or Pacific Islander race and eleven (16%) were of Hispanic ethnicity. Fourteen trainees (20%) identified as being the first person in their family to attend college. Among trainees, 24 (35%) were MDs, 30 (43%) were PhDs, and 9 (13%) held master’s degrees. Course lecture topics were rated, on average, as “essential” or “valuable” by 98% of trainees. Across lecture topics, on average, 48% of trainees rated their prior knowledge of topics as “very strong” or “strong,” and 11% of trainees rated their prior knowledge as “weak.” Overall, 52% of trainees evaluated their change in knowledge based on the lectures as “very much increased,” 46% as “somewhat” or “slightly” increased, and 2% as “no change.” Results were similar for the two tracks. Based on pre- and post-course assessments, trainees improved their knowledge of covered content (from 62% to 79% correct responses on knowledge assessments). Conclusion The IMPACT-AD course is achieving its mission of educating and diversifying the next generation of ADRD trialists. We thank Dr. Laurie Ryan and Dr. Kristina McLinden from the National Institute on Aging for their key contributions in leadership and scientific guidance of IMPACT-AD." @default.
• W4312087893 created "2023-01-04" @default.
• W4312087893 creator A5000626788 @default.
• W4312087893 creator A5001795846 @default.
• W4312087893 creator A5001912833 @default.
• W4312087893 creator A5002183686 @default.
• W4312087893 creator A5007748241 @default.
• W4312087893 creator A5009032548 @default.
• W4312087893 creator A5013224142 @default.
• W4312087893 creator A5021979900 @default.
• W4312087893 creator A5022540553 @default.
• W4312087893 creator A5026799001 @default.
• W4312087893 creator A5027031712 @default.
• W4312087893 creator A5030911639 @default.
• W4312087893 creator A5034225628 @default.
• W4312087893 creator A5045246745 @default.
• W4312087893 creator A5059549486 @default.
• W4312087893 creator A5060819071 @default.
• W4312087893 creator A5063637830 @default.
• W4312087893 creator A5065834232 @default.
• W4312087893 creator A5066821836 @default.
• W4312087893 creator A5066963436 @default.
• W4312087893 creator A5067354051 @default.
• W4312087893 creator A5068057129 @default.
• W4312087893 creator A5070100081 @default.
• W4312087893 creator A5076768887 @default.
• W4312087893 date "2022-12-01" @default.
• W4312087893 modified "2023-10-18" @default.
• W4312087893 title "The Institute on Methods and Protocols for Advancement of Clinical Trials for ADRD (IMPACT‐AD): An update after two years of conduct." @default.
• W4312087893 doi "https://doi.org/10.1002/alz.064617" @default.
• W4312087893 hasPublicationYear "2022" @default.
• W4312087893 type Work @default.
• W4312087893 citedByCount "0" @default.
• W4312087893 crossrefType "journal-article" @default.
• W4312087893 hasAuthorship W4312087893A5000626788 @default.
• W4312087893 hasAuthorship W4312087893A5001795846 @default.
• W4312087893 hasAuthorship W4312087893A5001912833 @default.
• W4312087893 hasAuthorship W4312087893A5002183686 @default.
• W4312087893 hasAuthorship W4312087893A5007748241 @default.
• W4312087893 hasAuthorship W4312087893A5009032548 @default.
• W4312087893 hasAuthorship W4312087893A5013224142 @default.
• W4312087893 hasAuthorship W4312087893A5021979900 @default.
• W4312087893 hasAuthorship W4312087893A5022540553 @default.
• W4312087893 hasAuthorship W4312087893A5026799001 @default.
• W4312087893 hasAuthorship W4312087893A5027031712 @default.
• W4312087893 hasAuthorship W4312087893A5030911639 @default.
• W4312087893 hasAuthorship W4312087893A5034225628 @default.
• W4312087893 hasAuthorship W4312087893A5045246745 @default.
• W4312087893 hasAuthorship W4312087893A5059549486 @default.
• W4312087893 hasAuthorship W4312087893A5060819071 @default.
• W4312087893 hasAuthorship W4312087893A5063637830 @default.
• W4312087893 hasAuthorship W4312087893A5065834232 @default.
• W4312087893 hasAuthorship W4312087893A5066821836 @default.
• W4312087893 hasAuthorship W4312087893A5066963436 @default.
• W4312087893 hasAuthorship W4312087893A5067354051 @default.
• W4312087893 hasAuthorship W4312087893A5068057129 @default.
• W4312087893 hasAuthorship W4312087893A5070100081 @default.
• W4312087893 hasAuthorship W4312087893A5076768887 @default.
• W4312087893 hasBestOaLocation W43120878931 @default.
• W4312087893 hasConcept C137403100 @default.
• W4312087893 hasConcept C138885662 @default.
• W4312087893 hasConcept C142724271 @default.
• W4312087893 hasConcept C144024400 @default.
• W4312087893 hasConcept C15744967 @default.
• W4312087893 hasConcept C19165224 @default.
• W4312087893 hasConcept C194051981 @default.
• W4312087893 hasConcept C2549261 @default.
• W4312087893 hasConcept C2778137410 @default.
• W4312087893 hasConcept C2987028688 @default.
• W4312087893 hasConcept C3020641676 @default.
• W4312087893 hasConcept C41895202 @default.
• W4312087893 hasConcept C509550671 @default.
• W4312087893 hasConcept C512399662 @default.
• W4312087893 hasConcept C535046627 @default.
• W4312087893 hasConcept C71924100 @default.
• W4312087893 hasConcept C74909509 @default.
• W4312087893 hasConcept C95457728 @default.
• W4312087893 hasConceptScore W4312087893C137403100 @default.
• W4312087893 hasConceptScore W4312087893C138885662 @default.
• W4312087893 hasConceptScore W4312087893C142724271 @default.
• W4312087893 hasConceptScore W4312087893C144024400 @default.
• W4312087893 hasConceptScore W4312087893C15744967 @default.
• W4312087893 hasConceptScore W4312087893C19165224 @default.
• W4312087893 hasConceptScore W4312087893C194051981 @default.
• W4312087893 hasConceptScore W4312087893C2549261 @default.
• W4312087893 hasConceptScore W4312087893C2778137410 @default.
• W4312087893 hasConceptScore W4312087893C2987028688 @default.
• W4312087893 hasConceptScore W4312087893C3020641676 @default.
• W4312087893 hasConceptScore W4312087893C41895202 @default.
• W4312087893 hasConceptScore W4312087893C509550671 @default.
• W4312087893 hasConceptScore W4312087893C512399662 @default.
• W4312087893 hasConceptScore W4312087893C535046627 @default.
• W4312087893 hasConceptScore W4312087893C71924100 @default.
• W4312087893 hasConceptScore W4312087893C74909509 @default.
• W4312087893 hasConceptScore W4312087893C95457728 @default.
• W4312087893 hasIssue "S10" @default.
• W4312087893 hasLocation W43120878931 @default.
• W4312087893 hasOpenAccess W4312087893 @default.
• W4312087893 hasPrimaryLocation W43120878931 @default.
• W4312087893 hasRelatedWork W1993031744 @default.

• next